Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BNY
Bank of New York Mellon
BNY
|
+$190M |
| 2 |
Lowe's Companies
LOW
|
+$183M |
| 3 |
Target
TGT
|
+$175M |
| 4 |
American Electric Power
AEP
|
+$174M |
| 5 |
NextEra Energy
NEE
|
+$152M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$6.19B |
| 2 |
Coty
COTY
|
+$1.11B |
| 3 |
Apple
AAPL
|
+$294M |
| 4 |
Meta Platforms (Facebook)
META
|
+$229M |
| 5 |
Microsoft
MSFT
|
+$192M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.41% |
| 2 | Financials | 12.33% |
| 3 | Energy | 10.93% |
| 4 | Industrials | 10.41% |
| 5 | Technology | 9.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HLTH
2526
DELISTED
Nobilis Health Corp.
HLTH
| $644K | ﹤0.01% |
+306,543
| New | +$834K |
|
2527
Barnes & Noble Education
BNED
$434M
| $642K | ﹤0.01% |
560
-2,086
| -79% | -$2.2M |
|
|
EAD
2528
Allspring Income Opportunities Fund
EAD
$377M
| $641K | ﹤0.01% |
+75,545
| New | +$617K |
|
2529
Oxford Industries
OXM
$579M
| $640K | ﹤0.01% |
10,648
-215,574
| -95% | -$14.2M |
|
2530
Stagwell
STGW
$2.11B
| $639K | ﹤0.01% |
97,600
-79,378
| -45% | -$587K |
|
2531
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.52B
| $637K | ﹤0.01% |
+10,409
| New | +$658K |
|
2532
Provident Financial Services
PFS
$3.07B
| $636K | ﹤0.01% |
+22,456
| New | +$559K |
|
2533
iShares MSCI USA Quality Factor ETF
QUAL
$47.8B
| $636K | ﹤0.01% |
9,207
+2,857
| +45% | +$194K |
|
|
TTPH
2534
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $634K | ﹤0.01% |
7,871
+977
| +14% | +$77.3K |
|
2535
Option Care Health
OPCH
$3.6B
| $632K | ﹤0.01% |
151,958
+141,203
| +1,313% | +$1.08M |
|
|
TWNK
2536
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
| $632K | ﹤0.01% |
+48,643
| New | +$590K |
|
|
CMCM
2537
Cheetah Mobile
CMCM
$94M
| $631K | ﹤0.01% |
13,209
+7,786
| +144% | +$413K |
|
|
PRA
2538
DELISTED
ProAssurance
PRA
| $631K | ﹤0.01% |
11,228
-7,389
| -40% | -$409K |
|
2539
Cardiff Oncology
CRDF
$76.6M
| $630K | ﹤0.01% |
4,164
+3,834
| +1,162% | +$895K |
|
|
TSRO
2540
DELISTED
TESARO, Inc.
TSRO
| $630K | ﹤0.01% |
+4,684
| New | +$591K |
|
2541
Golub Capital BDC
GBDC
$3.4B
| $628K | ﹤0.01% |
34,840
+13,420
| +63% | +$240K |
|
|
FOLD
2542
DELISTED
Amicus Therapeutics
FOLD
| $627K | ﹤0.01% |
+126,091
| New | +$873K |
|
|
AYR
2543
DELISTED
Aircastle Ltd
AYR
| $627K | ﹤0.01% |
30,058
-259,758
| -90% | -$5.48M |
|
2544
Vera Bradley
VRA
$95.3M
| $625K | ﹤0.01% |
53,353
-7,035
| -12% | -$96.9K |
|
2545
CALL
Geron
GERN
$983M
| $621K | ﹤0.01% |
+300,000
| New | +$633K |
|
2546
LivePerson
LPSN
$33.4M
| $619K | ﹤0.01% |
+5,469
| New | +$676K |
|
2547
Theravance Biopharma
TBPH
$884M
| $619K | ﹤0.01% |
+19,420
| New | +$602K |
|
|
TWOU
2548
DELISTED
2U Inc
TWOU
| $619K | ﹤0.01% |
+684
| New | +$697K |
|
|
TMX
2549
DELISTED
Terminix Global Holdings, Inc.
TMX
| $619K | ﹤0.01% |
+24,542
| New | +$602K |
|
2550
First Bancorp
FBNC
$2.64B
| $618K | ﹤0.01% |
22,784
-52,664
| -70% | -$1.22M |
|
Similar funds
Israel Englander's Q4 2016 Portfolio in Review
As of Q4 2016, Israel Englander held 4,092 positions worth $47.8B, down 20% from $59.6B the previous quarter. Its ten largest holdings account for 6.4% of the portfolio.
Israel Englander withdrew a net $13B in Q4 2016, closing 801 positions and reducing 1,159 holdings. Its most notable exit was Procter & Gamble, an estimated $6.19B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 11% a quarter earlier, followed by Financials and Energy.
Against the trend, Israel Englander opened a new position in Target worth $175M.
- Israel Englander's largest Q4 2016 buy was Target: 2,422,329 shares worth $175M.
- Israel Englander added most to Bank of New York Mellon in Q4 2016, an estimated $190M increase.
- Israel Englander's biggest Q4 2016 reduction was Coty, cutting an estimated $1.11B.
- Israel Englander fully exited Procter & Gamble in Q4 2016, selling an estimated $6.19B.
- Israel Englander's ten largest holdings make up 6.4% of its $47.8B portfolio in Q4 2016.
- Israel Englander opened 858 new positions and closed 801 in Q4 2016.
- Israel Englander's portfolio value fell 20% quarter-over-quarter to $47.8B.
Based on Millennium Management's 13F filing for Q4 2016, filed 14 Feb 2017.